These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37951694)

  • 1. Vaccine value profile for Group B streptococcus.
    Trotter CL; Alderson M; Dangor Z; Ip M; Le Doare K; Nakabembe E; Procter SR; Sekikubo M; Lambach P
    Vaccine; 2023 Nov; 41 Suppl 2():S41-S52. PubMed ID: 37951694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine value profile for invasive non-typhoidal Salmonella disease.
    Martin LB; Tack B; Marchello CS; Sikorski MJ; Owusu-Dabo E; Nyirenda T; Mogasale V; Crump JA
    Vaccine; 2024 Jul; 42(19S1):S101-S124. PubMed ID: 39003017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccines for maternal immunization against Group B Streptococcus disease: WHO perspectives on case ascertainment and case definitions.
    Seale AC; Baker CJ; Berkley JA; Madhi SA; Ordi J; Saha SK; Schrag SJ; Sobanjo-Ter Meulen A; Vekemans J
    Vaccine; 2019 Aug; 37(35):4877-4885. PubMed ID: 31303524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27-28 April 2016.
    Kobayashi M; Schrag SJ; Alderson MR; Madhi SA; Baker CJ; Sobanjo-Ter Meulen A; Kaslow DC; Smith PG; Moorthy VS; Vekemans J
    Vaccine; 2019 Nov; 37(50):7307-7314. PubMed ID: 28017431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of maternal immunisation against group B Streptococcus (GBS) disease: A modelling study.
    Giorgakoudi K; O'Sullivan C; Heath PT; Ladhani S; Lamagni T; Ramsay M; Al-Janabi H; Trotter C
    Vaccine; 2018 Nov; 36(46):7033-7042. PubMed ID: 30293765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Italian arm of the PREPARE study: an international project to evaluate and license a maternal vaccine against group B streptococcus.
    Berardi A; Cassetti T; Creti R; Vocale C; Ambretti S; Sarti M; Facchinetti F; Cose S; ; Heath P; Le Doare K
    Ital J Pediatr; 2020 Oct; 46(1):160. PubMed ID: 33115542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease burden of neonatal invasive Group B Streptococcus infection in the Netherlands.
    de Gier B; van Kassel MN; Sanders EAM; van de Beek D; Hahné SJM; van der Ende A; Bijlsma MW
    PLoS One; 2019; 14(5):e0216749. PubMed ID: 31071191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine value profile for Klebsiella pneumoniae.
    Dangor Z; Benson N; Berkley JA; Bielicki J; Bijsma MW; Broad J; Buurman ET; Cross A; Duffy EM; Holt KE; Iroh Tam PY; Jit M; Karampatsas K; Katwere M; Kwatra G; Laxminarayan R; Le Doare K; Mboizi R; Micoli F; Moore CE; Nakabembe E; Naylor NR; O'Brien S; Olwagen C; Reddy D; Rodrigues C; Rosen DA; Sadarangani M; Srikantiah P; Tennant SM; Hasso-Agopsowicz M; Madhi SA
    Vaccine; 2024 Jul; 42(19S1):S125-S141. PubMed ID: 38503661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value profile for respiratory syncytial virus vaccines and monoclonal antibodies.
    Fleming JA; Baral R; Higgins D; Khan S; Kochar S; Li Y; Ortiz JR; Cherian T; Feikin D; Jit M; Karron RA; Limaye RJ; Marshall C; Munywoki PK; Nair H; Newhouse LC; Nyawanda BO; Pecenka C; Regan K; Srikantiah P; Wittenauer R; Zar HJ; Sparrow E
    Vaccine; 2023 Nov; 41 Suppl 2():S7-S40. PubMed ID: 37422378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing a serocorrelate of protection against invasive group B streptococcus disease in pregnant women: a feasibility study.
    Carreras-Abad C; Cochet M; Hall T; Ramkhelawon L; Khalil A; Peregrine E; Vinayakarao L; Sivarajan S; Hamid R; Planche T; Sheridan E; Winchester S; Plumb J; Djennad A; Andrews N; Le Doare K; Heath P
    Health Technol Assess; 2019 Dec; 23(67):1-40. PubMed ID: 31855555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children.
    Seale AC; Bianchi-Jassir F; Russell NJ; Kohli-Lynch M; Tann CJ; Hall J; Madrid L; Blencowe H; Cousens S; Baker CJ; Bartlett L; Cutland C; Gravett MG; Heath PT; Ip M; Le Doare K; Madhi SA; Rubens CE; Saha SK; Schrag SJ; Sobanjo-Ter Meulen A; Vekemans J; Lawn JE
    Clin Infect Dis; 2017 Nov; 65(suppl_2):S200-S219. PubMed ID: 29117332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden.
    Gonçalves BP; Procter SR; Paul P; Chandna J; Lewin A; Seedat F; Koukounari A; Dangor Z; Leahy S; Santhanam S; John HB; Bramugy J; Bardají A; Abubakar A; Nasambu C; Libster R; Sánchez Yanotti C; Horváth-Puhó E; Sørensen HT; van de Beek D; Bijlsma MW; Gardner WM; Kassebaum N; Trotter C; Bassat Q; Madhi SA; Lambach P; Jit M; Lawn JE; ; ; ;
    Lancet Glob Health; 2022 Jun; 10(6):e807-e819. PubMed ID: 35490693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of a potential group B streptococcal vaccine for pregnant women in the United States.
    Kim SY; Nguyen C; Russell LB; Tomczyk S; Abdul-Hakeem F; Schrag SJ; Verani JR; Sinha A
    Vaccine; 2017 Oct; 35(45):6238-6247. PubMed ID: 28951085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances towards licensure of a maternal vaccine for the prevention of invasive group B streptococcus disease in infants: a discussion of different approaches.
    Absalon J; Simon R; Radley D; Giardina PC; Koury K; Jansen KU; Anderson AS
    Hum Vaccin Immunother; 2022 Dec; 18(1):2037350. PubMed ID: 35240933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospects for preventing infant invasive GBS disease through maternal vaccination.
    Madhi SA; Dangor Z
    Vaccine; 2017 Aug; 35(35 Pt A):4457-4460. PubMed ID: 28237500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine value profile for enterotoxigenic Escherichia coli (ETEC).
    Khalil I; Anderson JD; Bagamian KH; Baqar S; Giersing B; Hausdorff WP; Marshall C; Porter CK; Walker RI; Bourgeois AL
    Vaccine; 2023 Nov; 41 Suppl 2():S95-S113. PubMed ID: 37951695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attitudes of pregnant women in the Dominican Republic towards a future maternal Group B Streptococcus vaccine.
    Job MJ; Kim D; Acosta F; Valera S; Fernandez A; Laycock KM; Ratner AJ; Steenhoff AP; Feemster K; Geoghegan S
    Vaccine; 2024 Sep; 42(22):126169. PubMed ID: 39126829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants.
    Madhi SA; Dangor Z; Heath PT; Schrag S; Izu A; Sobanjo-Ter Meulen A; Dull PM
    Vaccine; 2013 Aug; 31 Suppl 4():D52-7. PubMed ID: 23973347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group B Streptococcus: Trials and Tribulations.
    Davies HG; Carreras-Abad C; Le Doare K; Heath PT
    Pediatr Infect Dis J; 2019 Jun; 38(6S Suppl 1):S72-S76. PubMed ID: 31205250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness.
    Procter SR; Gonçalves BP; Paul P; Chandna J; Seedat F; Koukounari A; Hutubessy R; Trotter C; Lawn JE; Jit M
    PLoS Med; 2023 Mar; 20(3):e1004068. PubMed ID: 36917564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.